Solid Tumor
Showing NaN - NaN of 94
Solid Tumor, Clear Cell Renal Cell Carcinoma, TNBC - Triple-Negative Breast Cancer Trial in United States (CB-839, Talazoparib)
Terminated
- Solid Tumor
- +6 more
-
Birmingham, Alabama
- +8 more
Feb 16, 2022
Urothelial Carcinoma, Urothelial Carcinoma Bladder, Bladder Cancer Trial in United States (IK-175, IK-175 and nivolumab)
Recruiting
- Urothelial Carcinoma
- +20 more
- IK-175
- IK-175 and nivolumab
-
Gilbert, Arizona
- +9 more
Feb 3, 2022
Cancer, Solid Tumor Trial in Houston (drug, biological, diagnostic test)
Completed
- Cancer
- Solid Tumor
- Fludarabine
- +5 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jan 14, 2022
Solid Tumor Trial in Houston (IPN60090, pembrolizumab, paclitaxel)
Solid Tumor, Cancer, Recurrent Solid Tumors Trial in Germany, United States (IMA201 Product, IMADetect®)
Recruiting
- Solid Tumor
- +3 more
- IMA201 Product
- IMADetect®
-
Chicago, Illinois
- +6 more
Dec 28, 2021
Subjects Treated With ACTR T Cell Product
Terminated
- B Cell Lymphomas
- +3 more
- ACTR T Cell Product
-
Gilbert, Arizona
- +15 more
Oct 4, 2021
Solid Tumor, Triple-negative Breast Cancer, Gastric Adenocarcinoma Trial in Houston, Chuo-Ku (LY3435151, Pembrolizumab)
Terminated
- Solid Tumor
- +8 more
-
Houston, Texas
- +1 more
Aug 4, 2021
Solid Tumor, Lymphoma Trial in Korea, Republic of, United States (IMC-002)
Recruiting
- Solid Tumor
- Lymphoma
- IMC-002
-
Saint Louis, Missouri
- +3 more
Jun 29, 2021
Ovarian Tumors, Tumors, Solid Tumor Trial in United States (Niraparib)
Completed
- Ovarian Neoplasms
- +3 more
-
Los Angeles, California
- +4 more
May 4, 2021
Solid Tumor, Hematologic Malignancies Trial in United States (LGX818)
Terminated
- Solid Tumor
- Hematologic Malignancies
-
Birmingham, Alabama
- +12 more
Mar 1, 2021
Solid Tumor, Colorectal Cancer Trial in United States (Magrolimab, Cetuximab)
Completed
- Solid Tumor
- Colorectal Cancer
-
Los Angeles, California
- +7 more
Feb 8, 2021